Navigation Links
First Molecular Tem-PCR Test to Identify Multiple Forms of Staph and MRSA Obtains CLIA Certificate
Date:8/4/2008

Identifies deadly hospital pathogens

A single, fast and accurate test identifies four Staph strains

simultaneously

HUNTSVILLE, Ala., Aug. 4 /PRNewswire/ -- Diatherix Laboratories, an independent clinical reference laboratory located in the Hudson-Alpha Institute for Biotechnology, announced today it has received its Clinical Laboratory Improvement Amendment (CLIA) certificate* for its proprietary licensed testing process, Target Enriched Multiplex Polymerase Chain Reaction (Tem-PCR). This molecular differential diagnostic technology is the first Tem- PCR test introduced to the clinical market which is able to identify multiple pathogens, both viral and bacterial in a single test. In less than four hours Tem-PCR can simultaneously differentiate pathogens with Staphylococcus and determine their associated drug resistance. Tem-PCR can identify four types of Staphylococcus strains, including the increasingly important bacterium known as Methicillin-resistant Staphylococcus aureus (MRSA).

The Centers for Disease Control and Prevention (CDC) has reported that MRSA infections have doubled in the past six years. The ability to accurately identify these pathogens is important because, beginning in October 2008, hospitals across the country may no longer receive Medicare reimbursement for many hospital acquired infections.

Prior to the Tem-PCR molecular technology, it was not possible to quickly and effectively differentiate between hospital-acquired infections (HAI) and community-acquired infections (CAI) in a single molecular test. Unlike hospital acquired MRSA which affects patients in a hospital, community-acquired MRSA often occurs in healthy people who are not receiving medical care and hospitalization. The ability to differentiate between CA-MRSA and HA-MRSA may assist hospitals in preventing non-reimbursement for MRSA infections.

"This revolutionary molecular testing technolog
'/>"/>

SOURCE Diatherix Laboratories Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014   ... II study investigating the efficacy and safety of MSB0010718C in ... is a rare and aggressive skin cancer lacking effective treatments   ... seven cohort Phase I clinical trial for the treatment of ... EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, ...
(Date:7/28/2014)... -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) ... audio webcast to discuss financial results for the second quarter ... 31, 2014 at 4:30 p.m. ET. Conference ... 31, 2014 Time: 4:30 PM ET Listen via Internet: ... A webcast replay will be available on the Pharmacyclics ...
(Date:7/28/2014)... FRANCISCO , July 28, 2014  Dignity ... it has received the Get With The Guidelines®-Stroke ... improvement measures outlined by the American Heart Association/American ... Stroke is the number four cause of death ... the United States , according ...
Breaking Medicine Technology:EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3
(Date:7/29/2014)... In his latest blog post at http://www.perwickstrom.com , ... has listed 6 ways to light the “fire” in employees. ... complacency, but for some it’s a losing battle,” commented ... ways to help employees get to the next level; which ... , According to Per Wickstrom, 6 ways to light the ...
(Date:7/29/2014)... 2014 In its latest blog post, ... and believes that having family close by during a ... whether or not the process is successful, has busted ... difficult to estimate just how damaging and destructive these ... Per Wickstrom . “Not only do they ensnare new ...
(Date:7/29/2014)... A Forever Recovery , an open-ended drug ... great start and gives them a solid foundation in recovery ... National Cherry Festival kickoff concert held on July 5, 2014 ... by Miller Lite and in partnership with WKLT Radio, saw ... Music Stage presented by Blue Cross Blue Shield and rock ...
(Date:7/29/2014)... July 29, 2014 Septic tanks ... of 5. This score reflects a buyer's moderate ability ... large number of suppliers, the product's widespread availability and ... IBISWorld analyst Jordan Weinstein. IBISWorld estimates that there are ... substantial number of supplier options. However, recent demand growth ...
(Date:7/29/2014)... Launched in 2012 by veteran anesthesiologist ... hangovers earlier this year at its Vegas location. Having ... the publication of research data related to the 20,000 ... The only licensed medical practice dedicated to the study, ... 2012 and treated thousands of patients within the first ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom’s Latest Blog Post Lists 6 Ways to Light the “Fire” in Employees 2Health News:Latest Best Drug Rehabilitation Blog Post Busts 4 Big Addiction Myths 2Health News:Latest Best Drug Rehabilitation Blog Post Busts 4 Big Addiction Myths 3Health News:A Forever Recovery Sponsors National Cherry Festival Kickoff Concert Featuring Collective Soul on July 5 in Traverse City, MI 2Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Septic Tanks Procurement Category Market Research Report Now Available from IBISWorld 4Health News:Hangover Heaven Surpasses 20,000 Hangovers 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 3
... HealthCore Finds Optimal Outcomes, Can Be ... Controllers, INDIANAPOLIS, July 8 Compliance ... outcomes, as measured by,reduced emergency room visits ... conducted by HealthCore, Inc., the health outcomes,research ...
... SUNNYVALE, Calif., July 8 ,Associates of Cape Cod, ... announce the launch of ACC,s Chromogenic LAL Endotoxin ... SoftMax(R) Pro GxP software., ACC and MDS ... part,11 solution for ACC,s Chromogenic LAL Endotoxin assay ...
... "a symmetric threat that imperils all nations", ... for Strategic Threat Analysis and Response (ISTAR),University of ... The following is by,Harvey Rubin, M.D., Ph.D., ... (ISTAR) University of Pennsylvania School of,Medicine:, The ...
... associated with mental disorders represent one of the ... today. This challenge is marked by the immense ... are their persistent increase due to an aging ... and, finally, the large unmet treatment needs, combined ...
... July 8, 2008 An analysis of more ... that darker-skinned patients benefit as those with lighter skin ... UT Southwestern Medical Center researchers show. , Phototherapy is ... ranging from common problems such as acne and psoriasis ...
... age of American moms may be behind increase in cases, ... heart attacks are rare among young women, becoming pregnant does ... , "This is a unique phenomenon in the sense ... have [heart attacks]," said lead researcher Dr. Uri Elkayam, a ...
Cached Medicine News:Health News:Study Measures Real-World Comparative Effectiveness of Asthma Controller Medications 2Health News:Study Measures Real-World Comparative Effectiveness of Asthma Controller Medications 3Health News:Study Measures Real-World Comparative Effectiveness of Asthma Controller Medications 4Health News:Associates of Cape Cod (ACC) and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform 2Health News:Associates of Cape Cod (ACC) and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform 3Health News:Proposing a New Global Compact for Infectious Diseases 2Health News:Proposing a New Global Compact for Infectious Diseases 3Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 2Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 3Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 4Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 5Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 6Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 7Health News:21st Congress of the College of Neuropsychopharmacology, Aug. 30-Sept. 3, 2008, Spain 8Health News:New research reveals ultraviolet light therapy is as beneficial for darker skin as lighter skin 2Health News:Pregnancy Boosts Heart Attack Risk 2
This is adapted to microplate or card....
Bio-Rad's ScanGel® cards for blood typing provide standardized protocols for all the cards: same incubation time (if required), same centrifugation time and speed....
Bio-Rad's ScanGel® cards for ABO reverse grouping, antibody screening and crossmatching include - ScanGel Neutral, ScanGel Coombs, Anti-IgG, -C3d (AHG), ScanGel Coombs + Neutral, ScanGel Anti-Ig...
... cell accommodates up to 12 large slab ... in the PROTEAN IEF system, for high-throughput ... PROTEAN Plus Dodeca cell's cooling and recirculating ... consistent, high-resolution results. The handcasting system includes ...
Medicine Products: